Clinical trial Recruiting at 1 site Observational Ages 18 and up

Creating a biological database for intensive care patients

Official title: Development of a Biological Database in the Field of Operative Intensive Care for the Recording of Clinically Relevant Parameters of Critically Ill Intensive Patients

Run by RWTH Aachen University · NCT03014427 · Data updated 2026-11-12

This study is trying to collect and store blood and urine samples from intensive care patients to help improve treatments and outcomes for future patients.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment99999999 (estimated)
SponsorRWTH Aachen University
Academic / other
Locations1 site (Aachen)
StatusRecruiting
StartedMarch 1, 2017
Main results expectedFebruary 2050
Study endsFebruary 2050
Registry record updatedSeptember 18, 2019
Trial IDNCT03014427 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients aged 18 years or older who are admitted to the intensive care unit and can provide informed consent.

Probably not a fit

Patients who are not admitted to the intensive care unit or those who cannot provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the collection and storage of biomaterial samples from patients admitted to the intensive care unit to support research aimed at improving prognosis and therapy. Patients will provide consent for the removal, transfer, and storage of their biomaterial, which will be collected during routine blood and urine sampling without any additional interventions. The study aims to establish a comprehensive biobank that adheres to official guidelines and facilitates future research in intensive care.

Why it matters

Potential benefit: If successful, this initiative could enhance the understanding of intensive care conditions and lead to improved treatment strategies for patients.

How similar studies have gone: Other studies utilizing biobanking in intensive care settings have shown promise in advancing research, indicating that this approach is both relevant and beneficial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients after admission to the intensive care unit
* 18 years or older
* signed informed consent

Exclusion Criteria:

* No exclusion criteria are formulated with regard to the objective of the register to record intensive care patients in general. Patients with multiple comorbidities, organ dysfunctions, and non-compliance for a curatively-intended therapy should also be recorded in the register. A palliative treatment or decision for best supportive care is not an exclusion criterion for registering.

Where it's running

  • Uniklinik RWTH Aachen
    Aachen, Germany
    Recruiting

Study contacts

  • Principal investigator: Christian Stoppe, Dr. med. — Operative Medicine and Intensive Care, RWTH Aachen University
  • Study coordinator: Christina Kalvelage, M. Sc.
  • Email: ckalvelage@ukaachen.de
  • Phone: 0241 80 36485

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • German registry for dementia and early memory problems

    This registry will collect clinical and biomarker information over time from people in Germany with subjective cognitive decline, mild cognitive impairment, or early dementia to see how symptoms and tests change.

    Recruiting at 21 sites RWTH Aachen University · Heidelberg, Baden-Wurttemberg and 23 other locations · NCT07433010

  • Stopping smoking before bronchoscopy or CT‑guided lung biopsy

    This project tests whether offering immediate quit-smoking support and measuring nicotine markers helps people who smoke and are having a bronchoscopy or CT‑guided lung biopsy stop smoking.

    Recruiting RWTH Aachen University · Aachen, North Rhine-Westphalia · NCT07322796

  • Assessing diaphragm function in patients with respiratory diseases

    This study is testing how well the diaphragm works in people with respiratory diseases to see if it affects their breathing difficulties and overall health.

    Recruiting RWTH Aachen University · Aachen, North Rhine-Westphalia · NCT05903001

  • How diaphragm strength changes during and after mechanical ventilation

    This project will try to see how quickly the diaphragm weakens in ICU patients on mechanical ventilation and whether it recovers after they are taken off the ventilator.

    Recruiting RWTH Aachen University · Aachen · NCT05211661

  • Investigating how lung diseases affect heart function

    This study is trying to see how chronic lung diseases like COPD and asthma affect heart function in patients using special heart imaging techniques.

    Recruiting RWTH Aachen University · Aachen · NCT05042219

  • Targeted radiation (SBRT) after TACE for liver cancer

    This study tests whether adding stereotactic body radiation therapy (SBRT) after trans-arterial chemoembolization (TACE) helps people with early or intermediate hepatocellular carcinoma who cannot have surgery.

    Recruiting RWTH Aachen University · Aachen, North Rhine-Westphalia · NCT04996914

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.